Skip to main content

Troy R. Nichols

Associate

TRNichols@mintz.com

+1.617.348.4833

Share:

Troy focuses his practice on mergers and acquisitions, private equity investments, joint ventures, capital markets transactions, securities law compliance, and corporate governance. He has experience with mergers, asset and equity acquisitions, leveraged buyouts, and other business combinations as well as platform acquisitions and add-ons, divestitures, restructurings, equity and debt financings, asset-backed lending, and refinancings. Troy advises clients across a variety of industries, including life sciences, biotechnology, medical technology, technology, financial services, industrial, and retail and consumer products.

Troy was previously a private equity associate at a global law firm, where he represented financial sponsors in a broad range of transactional matters. Earlier, he was a corporate Associate and Summer Associate at Mintz.

While attending law school, Troy was a law clerk for the US Attorney’s Office for the District of Columbia and a Maryland-based boutique litigation firm, and a judicial intern for the Honorable Nicholas E. Rattal of Prince George’s Circuit Court. In law school, Troy served as the financial director of the Trial Advocacy Team, treasurer of the Corporate & Finance Law Organization, and senior editor of the American Criminal Law Review.

Before attending law school, Troy worked as a corporate analyst at a multinational investment bank and financial services company.

News & Press

Press Release Thumbnail
Mintz attorneys in Boston, New York, and Washington, DC, closed four Private Equity transactions in the past month. Along with acquisitions for Charlesbank Capital Partners, DIF Capital Partners portfolio company Joink LLC, and Artemis Capital Partners, the firm represented the CEO and some managers of Salary.com in the sale of most of the company’s equity interests to Accel-KKR.
Press Release Thumbnail
Mintz took lead role for long-term client NanoView Biosciences in its sale to Unchained Labs, a portfolio company of The Carlyle Group. NanoView, through its ExoView technology, characterizes exosomes and the company’s LentiView platform complements Unchained Labs’ tools for gene therapy researchers working with lentivirus, which is an immunodeficiency virus that causes AIDS.
News Thumbnail
Mintz Member Marc Mantell and Associate Scott Dunberg co-authored an article published in the May 2020 issue of Wolters Kluwer’s Insights: The Corporate and Securities Law Advisor that examined a potential increase in the use of earnouts in mergers and acquisitions, as dealmaking has sputtered in reaction to the coronavirus pandemic. Mintz Associate Troy Nichols also contributed to this article.
Read less

Troy R. Nichols

Associate

Boston